DrugPatentWatch Database Preview

Details for Patent: 7,101,569

« Back to Dashboard

Which drugs does patent 7,101,569 protect, and when does it expire?

Patent 7,101,569 protects LEVOXYL and is included in one NDA.

This patent has twenty-six patent family members in nine countries.

Summary for Patent: 7,101,569

Title:	Methods of administering levothyroxine pharmaceutical compositions
Abstract:	The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions.
Inventor(s):	Franz; G. Andrew (St. Louis, MO), Strauss; Elaine A. (Seminole, FL), DiMenna; Phillip A. (St. Petersburg, FL), Gemma; Rocco L. (Dover, OH)
Assignee:
Application Number:	10/218,718
Patent Claim Types: see list of patent claims	Use; Composition; Dosage form;

Drugs Protected by US Patent 7,101,569

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted
King Pharms	LEVOXYL	levothyroxine sodium	TABLET;ORAL	021301-001	May 25, 2001	AB1,AB3	RX	Yes	No						METHOD OF USE OF ADMINISTERING LEVOTHYROXINE
King Pharms	LEVOXYL	levothyroxine sodium	TABLET;ORAL	021301-002	May 25, 2001	AB1,AB3	RX	Yes	No						METHOD OF USE OF ADMINISTERING LEVOTHYROXINE
King Pharms	LEVOXYL	levothyroxine sodium	TABLET;ORAL	021301-003	May 25, 2001	AB1,AB3	RX	Yes	No						METHOD OF USE OF ADMINISTERING LEVOTHYROXINE
King Pharms	LEVOXYL	levothyroxine sodium	TABLET;ORAL	021301-004	May 25, 2001	AB1,AB3	RX	Yes	No						METHOD OF USE OF ADMINISTERING LEVOTHYROXINE

Non-Orange Book US Patents Family Members for Patent 7,101,569

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No.	Title	Estimated Patent Expiration
6,555,581	Levothyroxine compositions and methods
7,067,148	Stabilized pharmaceutical and thyroid hormone compositions and method of preparation

International Family Members for US Patent 7,101,569

Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2002240394
Australia	2002258397
Australia	2002332507
Australia	2002341555